Cetirizine for Solar Urticaria in the Visible Spectrum
Sorry, there is no abstract. Read the first few lines of the text instead! Solar urticaria (SU) is an uncommon but well-recognized disorder characterized by the rapid development of an urticarial reaction in sun-exposed skin areas [1]. Various wavelengths, such as ultraviolet B (UVB:290-320 nm), ult...
Gespeichert in:
| Veröffentlicht in: | Dermatology (Basel) 2000-01, Vol.200 (4), p.334-335 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 335 |
|---|---|
| container_issue | 4 |
| container_start_page | 334 |
| container_title | Dermatology (Basel) |
| container_volume | 200 |
| creator | Monfrecola, Giuseppe Masturzo, Elvira Riccardo, Anna Maria Del Sorbo, Antonio |
| description | Sorry, there is no abstract. Read the first few lines of the text instead! Solar urticaria (SU) is an uncommon but well-recognized disorder characterized by the rapid development of an urticarial reaction in sun-exposed skin areas [1]. Various wavelengths, such as ultraviolet B (UVB:290-320 nm), ultraviolet A (UVA:320-400 nm) and visible light (VIS:400-760 nm), can be responsible for the condition [2-5]. Many therapies, such as phototherapy, photochemotherapy, H1 and H2 antihistamines, steroids, carotenoids or hydroxychloroquine, have been proposed, but their effectiveness is disappointing [6]. We report the data concerning the treatment of patients, suffering from SU elicited by VIS, with oral cetirizine and increasing whole-body sun exposure. Copyright © 2000 S. Karger AG, Basel |
| doi_str_mv | 10.1159/000018400 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_10894968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734912761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-d2aeb8c206509a37aca110ea56d642f9854802520dfa5dbf5c8bf1bb6ccc33033</originalsourceid><addsrcrecordid>eNpt0M1LwzAABfAgipvTg2dBgjcP1Xw0WXKU-gkTwTmvIU0TzdzWmrQH_euNdkwP5pIQfrwHD4BDjM4wZvIcpYNFjtAWGOKc4EwKSrbTO_1mgnM2AHsxzpMiYix3wQAjIXPJxRDwwrY--E-_stDVAU7rhQ5wFlpvdPAa-hVsXy189tGXCwunjTVt6Jb7YMfpRbQH63sEZtdXT8VtNnm4uSsuJpmhjLVZRbQthSGIMyQ1HWujMUZWM17xnDgpWC4QYQRVTrOqdMyI0uGy5MYYShGlI3DS5zahfu9sbNW87sIqVSoyzqXIKWYJnfbIhDrGYJ1qgl_q8KEwUt8Dqc1AyR6vA7tyaas_sl_kt_FNhxcbNuDy8f4nQTWVS-joX9R3fAHQAXMe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>274984315</pqid></control><display><type>article</type><title>Cetirizine for Solar Urticaria in the Visible Spectrum</title><source>Karger Journals</source><source>MEDLINE</source><creator>Monfrecola, Giuseppe ; Masturzo, Elvira ; Riccardo, Anna Maria ; Del Sorbo, Antonio</creator><creatorcontrib>Monfrecola, Giuseppe ; Masturzo, Elvira ; Riccardo, Anna Maria ; Del Sorbo, Antonio</creatorcontrib><description>Sorry, there is no abstract. Read the first few lines of the text instead! Solar urticaria (SU) is an uncommon but well-recognized disorder characterized by the rapid development of an urticarial reaction in sun-exposed skin areas [1]. Various wavelengths, such as ultraviolet B (UVB:290-320 nm), ultraviolet A (UVA:320-400 nm) and visible light (VIS:400-760 nm), can be responsible for the condition [2-5]. Many therapies, such as phototherapy, photochemotherapy, H1 and H2 antihistamines, steroids, carotenoids or hydroxychloroquine, have been proposed, but their effectiveness is disappointing [6]. We report the data concerning the treatment of patients, suffering from SU elicited by VIS, with oral cetirizine and increasing whole-body sun exposure. Copyright © 2000 S. Karger AG, Basel</description><identifier>ISSN: 1018-8665</identifier><identifier>EISSN: 1421-9832</identifier><identifier>DOI: 10.1159/000018400</identifier><identifier>PMID: 10894968</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Adolescent ; Adult ; Anti-Allergic Agents - therapeutic use ; Cetirizine - therapeutic use ; Dose-Response Relationship, Radiation ; Female ; Humans ; Letters to Dermatology ; Male ; Skin - drug effects ; Skin - pathology ; Skin - radiation effects ; Sunlight - adverse effects ; Urticaria - etiology ; Urticaria - pathology ; Urticaria - prevention & control</subject><ispartof>Dermatology (Basel), 2000-01, Vol.200 (4), p.334-335</ispartof><rights>2000 S. Karger AG, Basel</rights><rights>Copyright (c) 2000 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-d2aeb8c206509a37aca110ea56d642f9854802520dfa5dbf5c8bf1bb6ccc33033</citedby><cites>FETCH-LOGICAL-c355t-d2aeb8c206509a37aca110ea56d642f9854802520dfa5dbf5c8bf1bb6ccc33033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10894968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monfrecola, Giuseppe</creatorcontrib><creatorcontrib>Masturzo, Elvira</creatorcontrib><creatorcontrib>Riccardo, Anna Maria</creatorcontrib><creatorcontrib>Del Sorbo, Antonio</creatorcontrib><title>Cetirizine for Solar Urticaria in the Visible Spectrum</title><title>Dermatology (Basel)</title><addtitle>Dermatology</addtitle><description>Sorry, there is no abstract. Read the first few lines of the text instead! Solar urticaria (SU) is an uncommon but well-recognized disorder characterized by the rapid development of an urticarial reaction in sun-exposed skin areas [1]. Various wavelengths, such as ultraviolet B (UVB:290-320 nm), ultraviolet A (UVA:320-400 nm) and visible light (VIS:400-760 nm), can be responsible for the condition [2-5]. Many therapies, such as phototherapy, photochemotherapy, H1 and H2 antihistamines, steroids, carotenoids or hydroxychloroquine, have been proposed, but their effectiveness is disappointing [6]. We report the data concerning the treatment of patients, suffering from SU elicited by VIS, with oral cetirizine and increasing whole-body sun exposure. Copyright © 2000 S. Karger AG, Basel</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Allergic Agents - therapeutic use</subject><subject>Cetirizine - therapeutic use</subject><subject>Dose-Response Relationship, Radiation</subject><subject>Female</subject><subject>Humans</subject><subject>Letters to Dermatology</subject><subject>Male</subject><subject>Skin - drug effects</subject><subject>Skin - pathology</subject><subject>Skin - radiation effects</subject><subject>Sunlight - adverse effects</subject><subject>Urticaria - etiology</subject><subject>Urticaria - pathology</subject><subject>Urticaria - prevention & control</subject><issn>1018-8665</issn><issn>1421-9832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0M1LwzAABfAgipvTg2dBgjcP1Xw0WXKU-gkTwTmvIU0TzdzWmrQH_euNdkwP5pIQfrwHD4BDjM4wZvIcpYNFjtAWGOKc4EwKSrbTO_1mgnM2AHsxzpMiYix3wQAjIXPJxRDwwrY--E-_stDVAU7rhQ5wFlpvdPAa-hVsXy189tGXCwunjTVt6Jb7YMfpRbQH63sEZtdXT8VtNnm4uSsuJpmhjLVZRbQthSGIMyQ1HWujMUZWM17xnDgpWC4QYQRVTrOqdMyI0uGy5MYYShGlI3DS5zahfu9sbNW87sIqVSoyzqXIKWYJnfbIhDrGYJ1qgl_q8KEwUt8Dqc1AyR6vA7tyaas_sl_kt_FNhxcbNuDy8f4nQTWVS-joX9R3fAHQAXMe</recordid><startdate>20000101</startdate><enddate>20000101</enddate><creator>Monfrecola, Giuseppe</creator><creator>Masturzo, Elvira</creator><creator>Riccardo, Anna Maria</creator><creator>Del Sorbo, Antonio</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20000101</creationdate><title>Cetirizine for Solar Urticaria in the Visible Spectrum</title><author>Monfrecola, Giuseppe ; Masturzo, Elvira ; Riccardo, Anna Maria ; Del Sorbo, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-d2aeb8c206509a37aca110ea56d642f9854802520dfa5dbf5c8bf1bb6ccc33033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Allergic Agents - therapeutic use</topic><topic>Cetirizine - therapeutic use</topic><topic>Dose-Response Relationship, Radiation</topic><topic>Female</topic><topic>Humans</topic><topic>Letters to Dermatology</topic><topic>Male</topic><topic>Skin - drug effects</topic><topic>Skin - pathology</topic><topic>Skin - radiation effects</topic><topic>Sunlight - adverse effects</topic><topic>Urticaria - etiology</topic><topic>Urticaria - pathology</topic><topic>Urticaria - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monfrecola, Giuseppe</creatorcontrib><creatorcontrib>Masturzo, Elvira</creatorcontrib><creatorcontrib>Riccardo, Anna Maria</creatorcontrib><creatorcontrib>Del Sorbo, Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Dermatology (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monfrecola, Giuseppe</au><au>Masturzo, Elvira</au><au>Riccardo, Anna Maria</au><au>Del Sorbo, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cetirizine for Solar Urticaria in the Visible Spectrum</atitle><jtitle>Dermatology (Basel)</jtitle><addtitle>Dermatology</addtitle><date>2000-01-01</date><risdate>2000</risdate><volume>200</volume><issue>4</issue><spage>334</spage><epage>335</epage><pages>334-335</pages><issn>1018-8665</issn><eissn>1421-9832</eissn><abstract>Sorry, there is no abstract. Read the first few lines of the text instead! Solar urticaria (SU) is an uncommon but well-recognized disorder characterized by the rapid development of an urticarial reaction in sun-exposed skin areas [1]. Various wavelengths, such as ultraviolet B (UVB:290-320 nm), ultraviolet A (UVA:320-400 nm) and visible light (VIS:400-760 nm), can be responsible for the condition [2-5]. Many therapies, such as phototherapy, photochemotherapy, H1 and H2 antihistamines, steroids, carotenoids or hydroxychloroquine, have been proposed, but their effectiveness is disappointing [6]. We report the data concerning the treatment of patients, suffering from SU elicited by VIS, with oral cetirizine and increasing whole-body sun exposure. Copyright © 2000 S. Karger AG, Basel</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>10894968</pmid><doi>10.1159/000018400</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1018-8665 |
| ispartof | Dermatology (Basel), 2000-01, Vol.200 (4), p.334-335 |
| issn | 1018-8665 1421-9832 |
| language | eng |
| recordid | cdi_pubmed_primary_10894968 |
| source | Karger Journals; MEDLINE |
| subjects | Adolescent Adult Anti-Allergic Agents - therapeutic use Cetirizine - therapeutic use Dose-Response Relationship, Radiation Female Humans Letters to Dermatology Male Skin - drug effects Skin - pathology Skin - radiation effects Sunlight - adverse effects Urticaria - etiology Urticaria - pathology Urticaria - prevention & control |
| title | Cetirizine for Solar Urticaria in the Visible Spectrum |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A54%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cetirizine%20for%20Solar%20Urticaria%20in%20the%20Visible%20Spectrum&rft.jtitle=Dermatology%20(Basel)&rft.au=Monfrecola,%20Giuseppe&rft.date=2000-01-01&rft.volume=200&rft.issue=4&rft.spage=334&rft.epage=335&rft.pages=334-335&rft.issn=1018-8665&rft.eissn=1421-9832&rft_id=info:doi/10.1159/000018400&rft_dat=%3Cproquest_pubme%3E734912761%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=274984315&rft_id=info:pmid/10894968&rfr_iscdi=true |